 New York, New York--Newsfile Corp. - December 8, 2020 - Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. NASDAQ: SNOA resulting from allegations that Sonoma may have issued materially misleading business information to the investing public.On November 17, 2020, after market hours, Sonoma filed a Form 8-K with the U.S. Securities and Exchange Commission announcing that Sonomas unaudited... 